Shalby Ltd, a leading multi-specialty hospital chain in India, is known for its strong presence in healthcare services, particularly orthopedics and joint replacement. With increasing demand for quality healthcare and expanding operations across India, Shalby Ltd has drawn significant attention from investors. In this article, we will analyze Shalby’s current stock performance, its fundamentals, and share price targets from 2025 to 2030.
Let’s explore Shalby Ltd’s business, financial standing, and long-term price forecast.
Detail | Value |
---|---|
Open | ₹196.22 |
Previous Close | ₹196.22 |
Day’s High | ₹229.90 |
Day’s Low | ₹196.22 |
VWAP | ₹223.01 |
Volume | 11,088,340 |
Value (Lacs) | ₹24,283.46 |
Market Capitalization | ₹2,365 Cr |
Beta (Volatility) | 1.15 |
52-Week High | ₹297.90 |
52-Week Low | ₹177.25 |
All-Time High | ₹339.50 |
All-Time Low | ₹40.10 |
UC Limit | ₹235.46 |
LC Limit | ₹156.97 |
20D Avg Volume | 111,866 |
20D Avg Delivery (%) | 48.17 |
Book Value per Share | ₹93.25 |
Face Value | ₹10 |
Founded by Dr. Vikram Shah, Shalby Ltd is one of India’s leading hospital chains. The company specializes in joint replacements, orthopedics, and other multi-specialty healthcare services. With its network of hospitals spread across India, Shalby continues to expand into new healthcare verticals, strengthening its brand reputation.
Pioneer in joint replacement surgeries in India
Strong brand name in healthcare with growing patient base
Expanding hospital network and medical services
High promoter holding at 74.27%, reflecting confidence
Volatile but growth-oriented stock with Beta of 1.15
Investor Type | Holding (%) |
---|---|
Promoters | 74.27% |
Retail & Others | 20.33% |
Foreign Institutions | 5.20% |
Other Domestic Institutions | 0.19% |
This shareholding structure highlights strong promoter confidence and growing participation from foreign investors, which indicates rising trust in the company’s long-term growth.
Year | Minimum Target (₹) | Maximum Target (₹) |
---|---|---|
2025 | 210 | 240 |
2026 | 250 | 280 |
2027 | 290 | 325 |
2028 | 330 | 370 |
2029 | 360 | 410 |
2030 | 400 | 460 |
These targets are based on Shalby’s financial growth, healthcare demand in India, expansion strategy, and overall market sentiment.
Shalby’s stock is expected to show moderate growth in 2025, driven by rising healthcare demand and steady expansion.
Investment Advice: Investors can accumulate on dips as healthcare remains a defensive and growing sector.
In 2026, higher revenues from multi-specialty hospitals and better margins could drive the stock upward.
Why?
Rising healthcare spending in India
Strong promoter support ensuring long-term stability
Investment Advice: Suitable for long-term investors with medium risk appetite.
By 2027, Shalby is likely to benefit from expansion in Tier-2 and Tier-3 cities.
Why?
New hospitals adding to revenue
Brand recognition improving patient inflow
Investment Advice: Hold for compounding returns; good for SIP investors.
Increased medical tourism and higher operational efficiency may boost performance.
Investment Advice: Strong potential for long-term growth; watch for quarterly results.
Shalby may strengthen its position as a leading healthcare provider in India.
Why?
Increasing demand for quality healthcare services
Rising foreign institutional investor participation
Investment Advice: Excellent choice for medium- to long-term investors.
By 2030, Shalby could become one of the most recognized healthcare brands in India.
Why?
Strong promoter holding (74.27%) ensures stability
Expanding into global healthcare and medical tourism markets
Investment Advice: Good for long-term wealth creation in the healthcare sector.
Yes, Shalby Ltd is a strong long-term investment candidate. With rising healthcare demand in India, a robust promoter backing, and expansion into new regions, the company has potential for sustained growth.
Promoters hold a large stake (74.27%)
Strong hospital network and reputation in orthopedics
Healthcare is a defensive sector with stable growth
Book value per share at ₹93.25 supports valuation
Competition from other hospital chains
Regulatory changes in healthcare sector
Volatility due to higher Beta (1.15)
Shalby Ltd has established itself as a trusted name in the Indian healthcare sector, especially in joint replacement and multi-specialty hospital services. With its current price near ₹196 and a 52-week high of ₹297, Shalby has scope for long-term growth. Analysts expect the stock to trade between ₹400 and ₹460 by 2030, making it a promising option for investors looking for exposure to the healthcare industry.
1. What is the current share price of Shalby Ltd?
As of August 29, 2025, the share price is around ₹196.22.
2. What is the Shalby Ltd share price target for 2025?
The 2025 target is between ₹210 and ₹240.
3. Is Shalby Ltd a good long-term investment?
Yes, given the growing healthcare demand and strong promoter holding, it is suitable for long-term investors.
4. What is the 2030 target for Shalby Ltd?
By 2030, the stock is expected to reach between ₹400 and ₹460.
5. What is the 52-week high and low of Shalby Ltd?
The 52-week high is ₹297.90 and the low is ₹177.25.
6. What is Shalby Ltd’s market capitalization?
As of August 2025, the market cap is ₹2,365 Cr.
7. How much stake do promoters hold in Shalby Ltd?
Promoters hold 74.27% of the shares.
8. Is Shalby Ltd a volatile stock?
Yes, with a Beta of 1.15, it shows higher volatility compared to the market.
9. Does Shalby Ltd pay dividends?
Dividend policies may vary; investors should review financial reports for updates.
10. Should I buy Shalby Ltd stock now?
If you have a long-term investment horizon, Shalby can be a strong addition to your portfolio.
???? Disclaimer: This article is for educational purposes only. Stock market investments are subject to risks. Always consult a certified financial advisor before investing.